Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis

Intensive Care Medicine

Volumn 44, Issue 7, 2018, Pages 1003-1016

  Rygård, Sofie Louise ^a   Butler, Ethan ^b   Granholm, Anders ^a   Møller, Morten Hylander ^a,c   Cohen, Jeremy ^d,e   Finfer, Simon ^b,h   Perner, Anders ^a,c   Myburgh, John ^b,f   Venkatesh, Balasubramanian ^e,g   Delaney, Anthony ^h,i  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Centre for Research in Intensive Care   (Denmark)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f ST GEORGE HOSPITAL   (Australia)

^g WESLEY HOSPITAL   (Australia)

^h ROYAL NORTH SHORE HOSPITAL   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Corticosteroids; Meta analysis; Sepsis; Septic shock

Indexed keywords

CORTICOSTEROID; PLACEBO; GLUCOCORTICOID;

ARTIFICIAL VENTILATION; DISEASE DURATION; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; INTENSIVE CARE UNIT; LOW DRUG DOSE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPTIC SHOCK; SEQUENTIAL ANALYSIS; SYSTEMATIC REVIEW; ADULT; COMPARATIVE STUDY; DOSE RESPONSE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SHOCK, SEPTIC;

EID: 85046891476     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-018-5197-6     Document Type: Review

References (49)

1. Annane D (2005) Glucocorticoids in the treatment of severe sepsis and septic shock. Curr Opin Crit Care 11:449–453
2. Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New Engl J Med 332:1351–1362
3. Wagner HN Jr, Bennett IL Jr, Lasagna L, Cluff LE, Rosenthal MB, Mirick GS (1956) The Effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin. Bull Johns Hopkins Hosp 98:197–215
4. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, Fisher CJ Jr (1995) Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23:1430–1439
5. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27:723–732
6. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26:645–650
7. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. J Am Med Assoc 288:862–871
8. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J (2008) Hydrocortisone therapy for patients with septic shock. New Engl J Med 358:111–124
9. Annane D, Cariou A, Maxime V, Azoulay E, D’Honneur G, Timsit JF, Cohen Y, Wolf M, Fartoukh M, Adrie C, Santre C, Bollaert PE, Mathonet A, Amathieu R, Tabah A, Clec’h C, Mayaud J, Lejeune J, Chevret S (2010) Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. J Am Med Assoc 303:341–348
10. Moran JL, Graham PL, Rockliff S, Bersten AD (2010) Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a bayesian meta-analytic perspective. Crit Care 14:R134
11. Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, Cariou A, Forceville X, Schwebel C, Martin C, Timsit JF, Misset B, Ali Benali M, Colin G, Souweine B, Asehnoune K, Mercier E, Chimot L, Charpentier C, Francois B, Boulain T, Petitpas F, Constantin JM, Dhonneur G, Baudin F, Combes A, Bohe J, Loriferne JF, Amathieu R, Cook F, Slama M, Leroy O, Capellier G, Dargent A, Hissem T, Maxime V, Bellissant E (2018) Hydrocortisone plus fludrocortisone for adults with septic shock. New Engl J Med 378:809–818
12. Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, Billot L, Correa M, Glass P, Harward M, Joyce C, Li Q, McArthur C, Perner A, Rhodes A, Thompson K, Webb S, Myburgh J (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 378(9):797–808
13. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR (2005) Optimal search strategies for retrieving scientifically strong studies of treatment from medline: analytical survey. BMJ 330:1179
14. Wilczynski NL, McKibbon KA, Walter SD, Garg AX, Haynes RB (2013) Medline clinical queries are robust when searching in recent publishing years. J Am Med Inform Assoc 20:363–368
15. Wong SS, Wilczynski NL, Haynes RB (2006) Developing optimal search strategies for detecting clinically sound treatment studies in embase. J Med Libr Assoc 94:41–47
16. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JAC (2011) The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928
17. Wetterslev J, Thorlund K, Brok J, Gluud C (2009) Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol 9:86
18. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
19. Harbord RM, Egger M, Sterne JA (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25:3443–3457
20. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
21. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
22. Villar J, Mackey ME, Carroli G, Donner A (2001) Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models. Stat Med 20:3635–3647
23. Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C (2014) Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol 14:120
24. Wetterslev J, Jakobsen JC, Gluud C (2017) Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol 17:39
25. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O’Connell D, Oxman AD, Phillips B, Schunemann HJ, Edejer T, Varonen H, Vist GE, Williams JW Jr, Zaza S (2004) Grading quality of evidence and strength of recommendations. BMJ 328:1490
26. Aboab J, Polito A, Orlikowski D, Sharshar T, Castel M, Annane D (2008) Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach. Crit Care Med 36:1481–1486
27. Arabi YM, Aljumah A, Dabbagh O, Tamim HM, Rishu AH, Al-Abdulkareem A, Al Knawy B, Hajeer AH, Tamimi W, Cherfan A (2010) Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. Can Med Assoc J 182:1971–1977
28. Chawla K, Kupfer Y, Tessler S (1999) Hydrocortisone reverses refractory septic shock. Crit Care Med 27:A33
29. Cicarelli DD, Vieira JE, Bensenor FE (2007) Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med J 125:237–241
30. Cooperative Study Group (1963) The effectiveness of hydrocortisone in the management of severe infections: a double-blind study. JAMA 183:462–465
31. Deng QM, Shang D, Wan XY (2011) Effects of low-dose glucocorticoid on renal function and prognosis in patients with sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 23:183–184
32. Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, Brett SJ (2014) The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med 42:1325–1333
33. Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the vanish randomized clinical trial. JAMA 316:509–518
34. Hu B, Li JG, Liang H, Zhou Q, Yu Z, Li L, Luo Y, Liu C, Gan Q (2009) The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 21:529–531
35. Kurugundla N, Irugulapati L, Kilari D, Amchentsev A, Devakonda A, George L, Raoof S (2008) Effect of steroids in septic shock patients without relative adrenal insufficiency. International conference A, American Thoracic Society 116
36. Lv QQ, Gu XH, Chen QH, Yu JQ, Zheng RQ (2017) Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial. Am J Emerg Med 35(12):1810–1814
37. Meduri GU, Golden E, Umberger R (2009) Prospective double-blind randomized clinical trial on the effects of low-dose hydrocortisone infusion in patients with severe sepsis [abstract]. Chest 136:45S
38. Mirea L, Ungureanu R, Pavelescu D, Grintescu IC, Dumitrache C, Grintescu I, Mirea D (2014) Continuous administration of corticosteroids in septic shock can reduce risk of hypernatremia. Crit Care 18:S86
39. Oppert M, Schindler R, Husung C, Offermann K, Graf KJ, Boenisch O, Barckow D, Frei U, Eckardt KU (2005) Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 33:2457–2464
40. Tandan S, Guleria R, Gupta N (2005) Low dose steroids and adrenocortical insufficiency in septic shock: a double-blind randomised controlled trial from India. Am J Respir Crit Care Med 171:A43
41. Tongyoo S, Permpikul C, Mongkolpun W, Vattanavanit V, Udompanturak S, Kocak M, Meduri GU (2016) Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care 20:329
42. Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, Gabarrus A, Sellares J, Restrepo MI, Anzueto A, Niederman MS, Agusti C (2015) Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 313:677–686
43. Rinaldi L, Ferrari E, Marietta M, Donno L, Trevisan D, Codeluppi M, Busani S, Girardis M (2013) Effectiveness of sepsis bundle application in cirrhotic patients with septic shock: a single-center experience. J Crit Care 28:152–157
44. Venkatesh B, Finfer S, Myburgh J, Cohen J, Billot L (2018) Long-term outcomes of the ADRENAL trial. N Engl J Med 378(18):1744–1745
45. Resche-Rigon M, Azoulay E, Chevret S (2006) Evaluating mortality in intensive care units: contribution of competing risks analyses. Crit Care 10:R5
46. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y (2015) Corticosteroids for treating sepsis. Cochrane Database Syst Rev: Cd002243
47. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della Porta R, Giorgio C, Blasi F, Umberger R, Meduri GU (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171:242–248
48. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H (2003) Immunologic and hemodynamic effects of “low-dose” hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167:512–520
49. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. New Engl J Med 317:653–658